Search

everythinglearnresearchcommunity

for

Search:↓

PCOS requires personalized treatment to improve life quality and reduce health risks.

Endocrine disorders can cause various skin and hair issues.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Most skin changes during pregnancy go away after giving birth.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

No single treatment effectively cures hirsutism, and evidence for herbal remedies is weak.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Spironolactone most effective for hirsutism, but has side effects.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The method accurately measures steroid hormones in hair to study hormone dynamics related to hair loss.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Doctors should watch for and treat hormonal issues in obese patients beyond just diabetes.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.